Effects of drugs on beta-adrenergic receptors on human lymphocytes
- PMID: 6188922
- DOI: 10.1097/00005344-198300051-00010
Effects of drugs on beta-adrenergic receptors on human lymphocytes
Abstract
The density of beta-adrenergic receptors has been determined on membranes prepared from lymphocytes of normal human volunteers. Long-term administration of propranolol resulted in an increase in the density of receptors, whereas administration of the agonists ephedrine and terbutaline elicited a marked decrease in the density of receptors. These changes may explain the delayed side effects observed when propranolol administration is abruptly discontinued and the decreased efficacy that occurs during long-term administration of an agonist. In other experiments, pindolol, an antagonist with intrinsic sympathomimetic activity, was administered to normal subjects. A marked decrease in the density of receptors occurred within 1 day of administering pindolol. This effect persisted beyond the time at which pindolol administration was discontinued.
Similar articles
-
Effects of chronic administration of agonists and antagonists on the density of beta-adrenergic receptors.Am J Cardiol. 1986 Apr 25;57(12):17F-22F. doi: 10.1016/0002-9149(86)90883-0. Am J Cardiol. 1986. PMID: 2871741
-
Effects of pindolol and propranolol on beta adrenergic receptors on human lymphocytes.J Pharmacol Exp Ther. 1986 Oct;239(1):117-23. J Pharmacol Exp Ther. 1986. PMID: 3020227 Clinical Trial.
-
Effects of pindolol and propranolol on beta-adrenergic receptors on human lymphocytes.Br J Clin Pharmacol. 1982;13(Suppl 2):365S. doi: 10.1111/j.1365-2125.1982.tb01942.x. Br J Clin Pharmacol. 1982. PMID: 6285945 Free PMC article. No abstract available.
-
Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration.J Clin Invest. 1980 May;65(5):949-57. doi: 10.1172/JCI109781. J Clin Invest. 1980. PMID: 6102572 Free PMC article.
-
Alpha- and beta-adrenergic receptor subtypes properties, distribution and regulation.Drugs. 1984;28 Suppl 2:1-15. doi: 10.2165/00003495-198400282-00002. Drugs. 1984. PMID: 6098436 Review.
Cited by
-
[How many beta-receptor blockers does the physician need?].Klin Wochenschr. 1987 Mar 16;65(6):289-95. doi: 10.1007/BF01773455. Klin Wochenschr. 1987. PMID: 2884346 German. No abstract available.
-
Medical Management of Glaucoma in the 21st Century from a Canadian Perspective.J Ophthalmol. 2016;2016:6509809. doi: 10.1155/2016/6509809. Epub 2016 Nov 8. J Ophthalmol. 2016. PMID: 27895937 Free PMC article. Review.
-
Does treatment with beta-adrenergic blocking agents cause a decrease in beta 2-adrenoceptor affinity?Eur J Clin Pharmacol. 1992;42(6):613-8. doi: 10.1007/BF00265924. Eur J Clin Pharmacol. 1992. PMID: 1352497 Clinical Trial.
-
Beta-adrenoceptor antagonists (non-selective as well as beta 1-selective) with partial agonistic activity decrease beta 2-adrenoceptor density in human lymphocytes. Evidence for a beta 2-agonistic component of the partial agonistic activity.Naunyn Schmiedebergs Arch Pharmacol. 1986 Jun;333(2):130-8. doi: 10.1007/BF00506515. Naunyn Schmiedebergs Arch Pharmacol. 1986. PMID: 2875397
-
The role of endogenous noradrenaline in the beta-blocker withdrawal phenomenon--studies with cultured heart cells.Klin Wochenschr. 1987 Apr 1;65(7):308-16. doi: 10.1007/BF01745384. Klin Wochenschr. 1987. PMID: 2884347
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources